They’re prescription GLP-1–based medications used for chronic weight management. Semaglutide activates GLP-1; tirzepatide activates both GLP-1 and GIP, which can enhance appetite control and fullness signals.

They slow stomach emptying and improve appetite regulation in the brain, so you feel full sooner and stay full longer. They also improve insulin sensitivity, which can reduce cravings and help stabilize energy.

Adults with a BMI ≥30, or ≥27 with a weight-related condition (e.g., hypertension, prediabetes, high cholesterol), who are ready to pair medication with nutrition, movement, sleep, and stress strategies. We’ll screen for contraindications first.

Once weekly, subcutaneous injection. We start low and increase gradually to minimize side effects. Your exact plan is personalized based on response and tolerance.

Many people notice appetite changes within 1–2 weeks and steady weight changes over 4–8+ weeks as doses are optimized.

Nausea, fullness, heartburn, constipation/loose stools—usually mild and dose-related. We coach you on hydration, protein, fiber, and pacing dose increases to keep you comfortable.

People with a personal/family history of medullary thyroid carcinoma or MEN-2, active gallbladder disease, pancreatitis history, or during pregnancy/breastfeeding. We’ll review your medical history to be safe.

You’ll get the best results with simple, sustainable changes: adequate protein, high-fiber carbs, water, strength training 2–3×/week, and consistent sleep.

A tiny subcutaneous injection in the abdomen, thigh, or upper arm once weekly. Store vials/pens refrigerated per label. We teach you step-by-step administration.

See the pricing section on this page for current options. All plans include dosing guidance and ongoing support.